Differential presentation of tumor antigen‐derived epitopes by MHC‐class I and antigen‐positive tumor cells

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Journal of Cancer

• Publication date

  2008-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.23728PMID 18688854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards Imaging the Dynamics of Protein Signalling

  2007cited by this paper
• MHC‐peptide‐specific antibodies reveal inefficient presentation of an HLA‐A*0201‐restricted, Melan‐A‐derived peptide after active intracellular processing

  2007cited by this paper
• Traffic of Proteins and Peptides across Membranes for Immunosurveillance by CD8+ T Lymphocytes: A Topological Challenge

  2007cited by this paper
• Immunosuppressive strategies that are mediated by tumor cells.

  2007cited by this paper
• How TCRs bind MHCs, peptides, and coreceptors.

  2006cited by this paper
• Need for Tripeptidyl-peptidase II in Major Histocompatibility Complex Class I Viral Antigen Processing when Proteasomes are Detrimental*

  2006cited by this paper
• Coordinated downregulation of the antigen presentation machinery and HLA class I/β2‐microglobulin complex is responsible for HLA‐ABC loss in bladder cancer

  2005cited by this paper
• All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen‐processing pathway

  2005influential reference
• Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance

  2005cited by this paper
• Final Antigenic Melan-A Peptides Produced Directly by the Proteasomes Are Preferentially Selected for Presentation by HLA-A*0201 in Melanoma Cells1

  2004cited by this paper
• Dissecting cytotoxic T cell responses towards the NY‐ESO‐1 protein by peptide/MHC‐specific antibody fragments

  2004cited by this paper
• Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

  2004cited by this paper
• A critical role for Stat3 signaling in immune tolerance.

  2003cited by this paper
• An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope

  2003cited by this paper
• Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2.

  2003cited by this paper
• Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma1

  2002cited by this paper
• Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire.

  2002cited by this paper
• The SSX gene family: Characterization of 9 complete genes

  2002influential reference
• Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity

  2002cited by this paper
• Analysis of the B‐cell repertoire against antigens expressed by human neoplasms

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The Generation of Both T Killer and Th Cell Clones Specific for the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells1

  2001cited by this paper
• Discrete Cleavage Motifs of Constitutive and Immunoproteasomes Revealed by Quantitative Analysis of Cleavage Products

  2001cited by this paper
• Rexpression of HLA class I antigens and restoration of antigen‐specific CTL response in melanoma cells following 5‐aza‐2′‐deoxycytidine treatment

  2001cited by this paper
• Molecular strategies to define HLA haplotype loss in microdissected tumor cells.

  2000cited by this paper
• Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

  2000cited by this paper
• Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.

  2000cited by this paper
• A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies*

  1999cited by this paper
• Expression of SSX genes in human tumors

  1998cited by this paper
• beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

  1998cited by this paper
• Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.

  1998cited by this paper
• A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas

  1998cited by this paper
• Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

  1998cited by this paper
• Altered MHC class I antigens in tumors

  1997cited by this paper
• SSX: A multigene family with several members transcribed in normal testis and human cancer

  1997cited by this paper
• Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.

  1997cited by this paper
• T cell defined tumor antigens.

  1997cited by this paper
• Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.

  1996cited by this paper
• The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40.

  1996cited by this paper
• High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.

  1996cited by this paper
• High frequency of altered HLA class I phenotypes in invasive breast carcinomas.

  1996cited by this paper
• Phenotypic Analysis of Antigen-Specific T Lymphocytes

  1996cited by this paper
• Identification of human cancers deficient in antigen processing

  1993cited by this paper
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method

  year unknowncited by this paper

• Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications

  2022cites this paper
• Development of multiepitope therapeutic vaccines against the most prevalent high-risk human papillomaviruses.

  2020cites this paper
• T cell–induced CSF1 promotes melanoma resistance to PD1 blockade

  2018cites this paper
• A novel therapeutic vaccine composed of a rearranged human papillomavirus type 16 E6/E7 fusion protein and Fms-like tyrosine kinase-3 ligand induces CD8+ T cell responses and antitumor effect.

  2017cites this paper
• Aus der Klinik für Innere Medizin I der Medizinischen Fakultät der Universitätskliniken des Saarlandes

  2015cites this paper
• A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers

  2013cites this paper
• Vaccines Targeting the Cancer-testis Antigen SSX-2 Elicit HLA-A2 Epitope-specific Cytolytic T Cells

  2011cites this paper
• Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.

  2011cites this paper
• The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy

  2010cites this paper
• Immunotherapy for Glioblastoma

  2010cites this paper
• Untersuchungen zur Prozessierung und

  2009cites this paper
• Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.

  2009cites this paper
• Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.

  2009cites this paper